1 / 9

Shirin Heidari Rodney Kort

Shirin Heidari Rodney Kort. Map the Gap The research gaps in HIV treatment and prevention of women and children. Background. Objective in ILF Strategic Plan: 2008 – 2011

orea
Télécharger la présentation

Shirin Heidari Rodney Kort

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Shirin HeidariRodney Kort Map the Gap The research gaps in HIV treatment and prevention of women and children

  2. Background • Objective in ILF Strategic Plan: 2008 – 2011 • increase the number of HIV clinical research projects in resource-limited settings that industry is involved with that address the needs of women and children. • Outputs • Defining a research agenda for women in resource-poor countries, CROI 2008 • The role of industry in development of ARV-based prevention technologies for women, AIDS 2008 • Helping define a research agenda for women in Eastern Europe and Central Asia, EECAAC 2008 • Industry and HIV Clinical Research – what is being learned in Africa? Focusing on women and children, ICASA2008 www.iasociety.org/ilf

  3. Mapping Exercise • Goal: • Strengthen commitments to addressing priority clinical research on women and children • Objectives • Identify which organizations are involved in clinical research in low/middle income countries • Identify current research and outstanding priority research questions/knowledge gaps (state of the art review) • Identify barriers and opportunities for collaboration in addressing research questions • Establish consensus on how to advance this research agenda, including potential role of key stakeholders www.iasociety.org/ilf

  4. I Scope, partners and process • Confirm project scope, potential partners (e.g. ICRW, IPM, UNAIDS) and timelines with ILF AG • Review with 2 – 3 senior investigators in the field: ongoing resources • Refine scope/parameters of exercise based on inputs Timeline: February 2009 www.iasociety.org/ilf

  5. II Environmental Scan • Review of recent grey literature and scientific literature • Key informant interviews • Industry, normative agencies, NGOs, donors, academic research centres • Survey of IAS research membership/template data collection Timeline: March – April 2009 www.iasociety.org/ilf

  6. III Draft/Consult on Report • Environmental Scan Report and draft recommendations on priority research questions • Review of report and recommendations by expert panel (ILF, partners, key stakeholders) • Finalize report Timeline: May – June 2009 www.iasociety.org/ilf

  7. IV Special Session – IAS 2009 • Consultation on report recommendations at IAS 2009 co-sponsored by IAS and partners • Final revisions to report Timeline: July 2009 www.iasociety.org/ilf

  8. V Consensus Statement • Consensus statement based on final recommendations released by IAS and partners • Priority unmet research gaps • Role of industry and other key stakeholders in advancing priority research questions • Commitments by key stakeholders (?) Timeline: August 2009 www.iasociety.org/ilf

  9. Key Outputs • State of the art review on clinical research needs of women and children • Consultation at IAS 2009 • Consensus statement: recommendations for action www.iasociety.org/ilf

More Related